Hemostasis News and Research

RSS

Hemostasis or haemostasis is a complex process which causes the bleeding process to stop. Most times this includes the changing of blood from a fluid to a solid state. Intact blood vessels are central to moderating blood's tendency to clot.

Blocking IL6 pathway may prevent deadly skin ulcers in kidney disease

The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular diseases.

23 Apr 2025

Research describes blood disorders and their impact on Ebola patient outcomes

Announcing a new article publication for Zoonoses journal. Hematologic disorders occur frequently in patients with Ebola virus disease (EVD) and are characterized by one or several abnormalities in blood cells, including hemostasis, which is poorly documented. This study described the hematologic abnormalities of Ebola patients and the impact on the outcomes of patients who were admitted with EVD.

10 Apr 2025

Menstrual cycle may drive inflammation in women with sickle cell disease

A marker linked to inflammation, C-reactive protein, may increase significantly during the follicular phase of the menstrual cycle in female patients with sickle cell disease (SCD), according to emerging research published today in Blood Vessels, Thrombosis & Hemostasis.

9 Apr 2025

Researchers receive $2.7 million NIH grant to develop the next generation of synthetic blood

Blood loss is the leading cause of death in trauma patients between the ages of 1 and 46 years, largely because they cannot access safe blood sources quickly enough. A possible solution? Freeze-dried synthetic blood.

31 Mar 2025

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major bleeding, according to a study presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

29 Mar 2025

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and efficacy. While ischemic stroke rates were slightly higher, they were not statistically significant, warranting further phase 3 trials for confirmation.

23 Jan 2025

The diverse immunological functions of megakaryocytes

Megakaryocytes (MKs), known for their role in platelet production, have emerged as critical players in immune responses, showcasing versatility in both physiological and pathological contexts.

17 Jan 2025

Protamine sulfate reduces postoperative compression time after dTRA coronary angiography

Announcing a new article publication for Cardiovascular Innovations and Applications journal. With distal transradial access (dTRA), the postoperative compression time remains significantly longer than the recommended range via in practice.

16 Jan 2025

University Hospitals first in Northeast Ohio to use Da Vinci 5 for robotic-assisted surgeries

University Hospitals is the first health system in Northeast Ohio utilizing the Da Vinci 5 for robotic-assisted surgeries.

16 Dec 2024

Understanding cardiovascular risks in endometriosis patients

Endometriosis increases the risk of cardiovascular events.

18 Oct 2024

Groundbreaking antimicrobial bandage offers rapid hemostasis in accidents

Without proper medical invention, injuries sustained from traffic collisions, serious workplace accidents or weapons may result in fatal hemorrhaging.

16 Oct 2024

Traditional Chinese medicine shows potential in cancer treatment

Cancer, a pervasive global health concern, remains a leading cause of mortality worldwide. Current cancer treatment modalities encompass surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy, all of which have significantly contributed to improving patient survival.

1 Oct 2024

Fibrin fuels thromboinflammation and brain damage in COVID-19

Researchers reveal fibrin's critical role in COVID-19 by driving thromboinflammation and neuropathology, and highlight a potential antibody therapy to mitigate these effects.

29 Aug 2024

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and prevention of bleeds and perioperative prophylaxis in hemophilia A. ALTUVOCT is a high-sustained factor VIII replacement therapy for all ages and any disease severity.

22 Jun 2024

Heavy menstrual bleeding raises heart disease risk in young women

Study found that heavy menstrual bleeding (HMB) is linked to increased cardiovascular disease (CVD) risk in young women, even without irregular menstruation.

28 May 2024

Innovative material swiftly stops kidney bleeding and facilitates wound recovery

Professor Dong-Woo Cho from the Department of Mechanical Engineering along with Jae Yun Kim, a PhD candidate, from the School of Interdisciplinary Bioscience and Bioengineering and Tugce Sen, a PhD student, from Department of Mechanical Engineering at POSTECH, teamed up with Professor Jae Yeon Lee from Daegu Haany University's Department of Companion Animal Health.

2 May 2024

Hemostasis News and Research

Blocking IL6 pathway may prevent deadly skin ulcers in kidney disease

Research describes blood disorders and their impact on Ebola patient outcomes

Menstrual cycle may drive inflammation in women with sickle cell disease

Researchers receive $2.7 million NIH grant to develop the next generation of synthetic blood

Bentracimab reverses ticagrelor's antiplatelet effects during surgery and bleeding events

Study reveals abelacimab’s potential to improve anticoagulation safety for AFib patients

The diverse immunological functions of megakaryocytes

Protamine sulfate reduces postoperative compression time after dTRA coronary angiography

University Hospitals first in Northeast Ohio to use Da Vinci 5 for robotic-assisted surgeries

Understanding cardiovascular risks in endometriosis patients

Groundbreaking antimicrobial bandage offers rapid hemostasis in accidents

Traditional Chinese medicine shows potential in cancer treatment

Fibrin fuels thromboinflammation and brain damage in COVID-19

Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization

Heavy menstrual bleeding raises heart disease risk in young women

Innovative material swiftly stops kidney bleeding and facilitates wound recovery

Wound warriors: How microbes influence healing and infection risks

Researchers develop bilayer adhesive hemostat using proteins derived from mussels and silkworms

New drug shows promise in blocking pancreatic cancer spread

New clinical trial shows simple way to save thousands of units of blood every year

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News